Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VectorY Therapeutics
Biotech
VectorY pens $1.2B pact to use Shape's brain-penetrating capsid
VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain.
James Waldron
Sep 18, 2025 9:25am
Protara gears up for next commercial steps—Chutes & Ladders
Jun 6, 2025 8:30am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
FDA's principal deputy to depart agency—Chutes & Ladders
Dec 20, 2024 8:30am
VectorY raises $138M to push forward ALS program
Nov 13, 2023 10:26am
Seagen finally finds new CEO—Chutes & Ladders
Nov 11, 2022 9:30am
